Surf Therapeutics
Palo Alto, CA
- Neuromodulation
Surf Therapeutics is developing a non-invasive, at-home ultrasound neuromodulation platform for chronic inflammatory and autoimmune disorders. Its patented broad-beam ultrasound technology is designed to stimulate the spleen-brain axis and activate the cholinergic anti-inflammatory pathway, helping restore immune balance without relying on drugs.
- TrialClinical trial
- 1
What makes Surf Therapeutics distinct
- 01Patented broad-beam ultrasound stimulation designed for non-invasive, at-home use.
- 02Targets the body's cholinergic anti-inflammatory pathway to help regulate overactive immune responses.
- 03Drug-free therapeutic approach intended to harness the body's natural mechanisms for controlling inflammation.
- 04Platform technology may support treatment across multiple inflammatory and autoimmune disorders, including rheumatoid arthritis, psoriasis, psoriatic arthritis, and multiple sclerosis.
- 05Led by a multidisciplinary team spanning medicine, neuroscience, engineering, and biotechnology.
Technology & products
- Patented broad-beam ultrasound stimulation platform
- Non-invasive at-home ultrasound neuromodulation
- Spleen-brain axis and cholinergic anti-inflammatory pathway stimulation
Clinical trials1
- Ultrasound Neuroimmune Modulation in Adults With Rheumatoid ArthritisRecruitingNCT07293871 · 40 participants · started Mar 2026
- Rheumatoid Arthritis
In the Cortex
Similar companies
About Surf Therapeutics
- Headquarters
- Palo Alto, CA